BridgeBio Pharma, Inc. (BBIO) Return on equity 2019–2020
BridgeBio Pharma, Inc. (BBIO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-872.9%FY2020 · since FY2019: -70.7% → -872.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | -872.9% | -802.3 pp |
| FY2019 | -70.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice